Correlation Between Pharmala Biotech and Sosei Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmala Biotech and Sosei Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmala Biotech and Sosei Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmala Biotech Holdings and Sosei Group, you can compare the effects of market volatilities on Pharmala Biotech and Sosei Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmala Biotech with a short position of Sosei Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmala Biotech and Sosei Group.

Diversification Opportunities for Pharmala Biotech and Sosei Group

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pharmala and Sosei is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Pharmala Biotech Holdings and Sosei Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sosei Group and Pharmala Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmala Biotech Holdings are associated (or correlated) with Sosei Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sosei Group has no effect on the direction of Pharmala Biotech i.e., Pharmala Biotech and Sosei Group go up and down completely randomly.

Pair Corralation between Pharmala Biotech and Sosei Group

Assuming the 90 days horizon Pharmala Biotech Holdings is expected to generate 2.95 times more return on investment than Sosei Group. However, Pharmala Biotech is 2.95 times more volatile than Sosei Group. It trades about 0.02 of its potential returns per unit of risk. Sosei Group is currently generating about 0.01 per unit of risk. If you would invest  31.00  in Pharmala Biotech Holdings on September 2, 2024 and sell it today you would lose (6.00) from holding Pharmala Biotech Holdings or give up 19.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy9.05%
ValuesDaily Returns

Pharmala Biotech Holdings  vs.  Sosei Group

 Performance 
       Timeline  
Pharmala Biotech Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pharmala Biotech Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Pharmala Biotech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Sosei Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sosei Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pharmala Biotech and Sosei Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmala Biotech and Sosei Group

The main advantage of trading using opposite Pharmala Biotech and Sosei Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmala Biotech position performs unexpectedly, Sosei Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sosei Group will offset losses from the drop in Sosei Group's long position.
The idea behind Pharmala Biotech Holdings and Sosei Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bonds Directory
Find actively traded corporate debentures issued by US companies